- Home
- ALDX vs PKE Comparison
ALDX vs PKE Comparison
Compare ALDX & PKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- PKE
- Stock Information
- Founded
- ALDX 2004
- PKE 1954
- Country
- ALDX United States
- PKE United States
- Employees
- ALDX N/A
- PKE N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- PKE Military/Government/Technical
- Sector
- ALDX Health Care
- PKE Industrials
- Exchange
- ALDX Nasdaq
- PKE Nasdaq
- Market Cap
- ALDX 304.9M
- PKE 285.7M
- IPO Year
- ALDX 2014
- PKE N/A
- Fundamental
- Price
- ALDX $6.35
- PKE $13.43
- Analyst Decision
- ALDX Strong Buy
- PKE
- Analyst Count
- ALDX 2
- PKE 0
- Target Price
- ALDX $10.00
- PKE N/A
- AVG Volume (30 Days)
- ALDX 560.3K
- PKE 51.5K
- Earning Date
- ALDX 05-01-2025
- PKE 01-14-2025
- Dividend Yield
- ALDX N/A
- PKE 3.73%
- EPS Growth
- ALDX N/A
- PKE N/A
- EPS
- ALDX N/A
- PKE 0.36
- Revenue
- ALDX N/A
- PKE $61,420,000.00
- Revenue This Year
- ALDX N/A
- PKE N/A
- Revenue Next Year
- ALDX N/A
- PKE N/A
- P/E Ratio
- ALDX N/A
- PKE $37.19
- Revenue Growth
- ALDX N/A
- PKE 15.45
- 52 Week Low
- ALDX $2.71
- PKE $11.96
- 52 Week High
- ALDX $6.92
- PKE $16.96
- Technical
- Relative Strength Index (RSI)
- ALDX 55.70
- PKE 35.96
- Support Level
- ALDX $4.78
- PKE $13.18
- Resistance Level
- ALDX $6.52
- PKE $13.97
- Average True Range (ATR)
- ALDX 0.53
- PKE 0.34
- MACD
- ALDX -0.06
- PKE -0.04
- Stochastic Oscillator
- ALDX 73.36
- PKE 23.25
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.
About PKE Park Aerospace Corp.
Park Aerospace Corp designs develop and manufactures engineered, advanced composite materials and composite structures and assemblies and low-volume tooling for the aerospace markets and prototype tooling for such structures and assemblies. Geographically, the company derives a majority of revenue from North America and also has a presence in a company operates its business in Asia and Europe. It offers advanced composite Prepregs for Aircraft Structures and Interiors, Sigma Strut and Alpha Strut.